Tennessee Clinical Research Center   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Nashville TN United States (2002)

Organization Overview

First Clinical Trial
2005
NCT00110760
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Tennessee Clinical Research Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erythema (Phase 3)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6